F. S. Abbott

Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca

Dennis J. McKenna, G.H.N. Towers, F. S. Abbott · Journal of Ethnopharmacology · 1984 · 392 citations

Cannabis Use, Psychoactive Drug, Monoamine Oxidase Inhibitors +7

Contribution of CYP2C9, CYP2A6, and CYP2B6 to Valproic Acid Metabolism in Hepatic Microsomes from Individuals with the CYP2C9*1/*1 Genotype

Tony K. L. Kiang, P. C. Ho, M. Reza Anari et al. · Toxicological Sciences · 2006 · 158 citations

Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.

Kelem Kassahun, K Farrell, F. S. Abbott · Drug Metabolism and Disposition · 1991 · 104 citations

Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes

P. C. Ho, F. S. Abbott, Ulrich M. Zanger et al. · The Pharmacogenomics Journal · 2003 · 98 citations

Valproic Acid, Cyp2c9 Genotypes, Hepatology +14

Monoamine oxidase inhibitors in South American hallucinogenic plants part 2: Constituents of orally-active Myristicaceous hallucinogens

Dennis J. McKenna, G.H.N. Towers, F. S. Abbott · Journal of Ethnopharmacology · 1984 · 62 citations

Medicinal Chemistry, Monoamine Oxidase Inhibitors, Biochemistry +8